# Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

> **NCT02971345** · PHASE3 · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 253 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Portal Vein Tumor Thrombus

## Interventions

- **PROCEDURE:** Stent and Iodine-125 seed strand implantation
- **DEVICE:** Stent
- **DEVICE:** Iodine-125 seed
- **DRUG:** Epirubicin
- **DRUG:** Ultra-fluid lipiodol
- **OTHER:** Gelatin sponge articles

## Key facts

- **NCT ID:** NCT02971345
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2020-10
- **Final completion:** 2020-11
- **Target enrollment:** 253 (ESTIMATED)
- **Last updated:** 2020-06-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02971345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02971345, "Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02971345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*